Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.
作者信息
Schrump David S, Hong Julie A
机构信息
Thoracic Epigenetics Section, Thoracic and Oncologic Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Md.
Thoracic Epigenetics Section, Thoracic and Oncologic Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Md.
出版信息
J Thorac Cardiovasc Surg. 2018 Jun;155(6):2632-2633. doi: 10.1016/j.jtcvs.2018.01.060. Epub 2018 Feb 8.
Abstract
摘要
相似文献
1
Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.循环肿瘤DNA分析：肺癌检测与治疗的下一个范式转变。
J Thorac Cardiovasc Surg. 2018 Jun;155(6):2632-2633. doi: 10.1016/j.jtcvs.2018.01.060. Epub 2018 Feb 8.
2
[Research progress of circulating tumor DNA methylation in non-small cell lung cancer].非小细胞肺癌中循环肿瘤DNA甲基化的研究进展
Zhonghua Jie He He Hu Xi Za Zhi. 2018 Dec 12;41(12):967-970. doi: 10.3760/cma.j.issn.1001-0939.2018.12.013.
3
Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.检测非小细胞肺癌脑转移患者脑脊液样本中的循环肿瘤 DNA。
Thorac Cancer. 2020 Mar;11(3):588-593. doi: 10.1111/1759-7714.13300. Epub 2020 Jan 13.
4
Circulating tumor DNA: Solid data from liquid biopsies.循环肿瘤DNA：液体活检的可靠数据。
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1132-1133. doi: 10.1016/j.jtcvs.2017.05.059. Epub 2017 May 25.
5
Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.对非小细胞肺癌患者血浆中循环肿瘤 DNA 进行分析，使用珠子、乳液、扩增和磁珠辅助检测法监测表皮生长因子受体 p.T790M 突变等位基因分数，并评估其在模拟循环肿瘤细胞中的未来应用。
Cancer Med. 2019 Jul;8(8):3685-3697. doi: 10.1002/cam4.2244. Epub 2019 May 21.
6
Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.BRAF 突变型肺腺癌中循环肿瘤细胞和循环肿瘤 DNA 中 BRAF 突变的检测与监测
J Thorac Oncol. 2016 Sep;11(9):e109-12. doi: 10.1016/j.jtho.2016.05.001. Epub 2016 May 7.
7
Cell-free tumour DNA as a diagnostic and prognostic biomarker in non-small cell lung carcinoma.游离肿瘤DNA作为非小细胞肺癌的诊断和预后生物标志物
Adv Respir Med. 2019;87(2):118-122. doi: 10.5603/ARM.2019.0019.
8
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy.液体活检推动非小细胞肺癌精准治疗。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818801809. doi: 10.1177/1533033818801809.
9
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.无需活检的循环肿瘤DNA检测可识别肺癌中的可靶向治疗突变。
Oncotarget. 2016 Oct 11;7(41):66880-66891. doi: 10.18632/oncotarget.11801.
10
Single tube liquid biopsy for advanced non-small cell lung cancer.单管液体活检用于晚期非小细胞肺癌。
Int J Cancer. 2019 Jun 15;144(12):3127-3137. doi: 10.1002/ijc.32056. Epub 2019 Jan 28.
本文引用的文献
1
Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.循环肿瘤DNA：一种指导非小细胞肺癌术后治疗和监测的有前景的生物标志物。
J Thorac Cardiovasc Surg. 2018 Jun;155(6):2628-2631. doi: 10.1016/j.jtcvs.2017.12.157. Epub 2018 Mar 13.
2
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA.通过循环肿瘤 DNA 早期评估肺癌免疫治疗反应。
Clin Cancer Res. 2018 Apr 15;24(8):1872-1880. doi: 10.1158/1078-0432.CCR-17-1341. Epub 2018 Jan 12.
3
Immune checkpoint inhibitors in advanced non-small cell lung cancer.免疫检查点抑制剂在晚期非小细胞肺癌中的应用。
Cancer. 2018 Jan 15;124(2):248-261. doi: 10.1002/cncr.31105. Epub 2017 Dec 6.
4
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.局部肺癌中循环肿瘤 DNA 谱分析的分子残留疾病的早期检测。
Cancer Discov. 2017 Dec;7(12):1394-1403. doi: 10.1158/2159-8290.CD-17-0716. Epub 2017 Sep 24.
5
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.系统发育ctDNA分析描绘了早期肺癌的演变。
Nature. 2017 Apr 26;545(7655):446-451. doi: 10.1038/nature22364.
6
Precision Therapy for Lung Cancer: Tyrosine Kinase Inhibitors and Beyond.肺癌的精准治疗：酪氨酸激酶抑制剂及其他
Semin Thorac Cardiovasc Surg. 2015 Spring;27(1):36-48. doi: 10.1053/j.semtcvs.2015.04.002. Epub 2015 Apr 8.
7
Reduced lung-cancer mortality with low-dose computed tomographic screening.低剂量计算机断层扫描筛查可降低肺癌死亡率。
N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
8
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.表皮生长因子受体中的激活突变是非小细胞肺癌对吉非替尼产生反应的基础。
N Engl J Med. 2004 May 20;350(21):2129-39. doi: 10.1056/NEJMoa040938. Epub 2004 Apr 29.
Zotero 插件